 | • レポートコード：C-GIR20G2942 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「ホスホジエステラーゼタイプ5（PDE5）阻害剤の世界市場2019年」は、グローバルにおけるホスホジエステラーゼタイプ5（PDE5）阻害剤市場を展望するレポートです。ホスホジエステラーゼタイプ5（PDE5）阻害剤のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の市場概観 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の世界市場規模 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のアメリカ市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のカナダ市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のメキシコ市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のドイツ市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のイギリス市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のロシア市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の日本市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の中国市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の韓国市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤のインド市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の東南アジア市場規模推移 ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の南米市場分析（ブラジル、アルゼンチン等） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の種類別分析/販売量、売上、市場シェア（シルデナフィル、タダラフィル、アバナフィル、バルデナフィル） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の用途別分析/市場規模（病院、小売薬局、オンライン薬局、その他） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ホスホジエステラーゼタイプ5（PDE5）阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Description
Scope of the Report:
The global Phosphodiesterase Type 5 (PDE5) Inhibitor market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Phosphodiesterase Type 5 (PDE5) Inhibitor.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Phosphodiesterase Type 5 (PDE5) Inhibitor market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Phosphodiesterase Type 5 (PDE5) Inhibitor market by product type and applications/end industries.
Market Segment by Companies, this report covers
Eli Lilly
AstraZeneca
Novartis AG
Pfizer
Roche
Bayer
SK Chemicals
GlaxoSmithKline plc
Merck
BaiYunShan General Factory
Vectura Group
Teva Pharma
Seoul Pharma
Dong-A ST
Metuchen Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sildenafil
Tadalafil
Avanafil
Vardenafil
Market Segment by Applications, can be divided into
Hospital
Retail Pharmacy
Online Pharmacies
Other
Table of Contents
1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Overview
1.1 Product Overview and Scope of Phosphodiesterase Type 5 (PDE5) Inhibitor
1.2 Classification of Phosphodiesterase Type 5 (PDE5) Inhibitor by Types
1.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Comparison by Types (2019-2024)
1.2.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Types in 2018
1.2.3 Sildenafil
1.2.4 Tadalafil
1.2.5 Avanafil
1.2.6 Vardenafil
1.3 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market by Application
1.3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market by Regions
1.4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Phosphodiesterase Type 5 (PDE5) Inhibitor Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Phosphodiesterase Type 5 (PDE5) Inhibitor Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Phosphodiesterase Type 5 (PDE5) Inhibitor Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Phosphodiesterase Type 5 (PDE5) Inhibitor Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Phosphodiesterase Type 5 (PDE5) Inhibitor Status and Prospect (2014-2024)
1.5 Global Market Size of Phosphodiesterase Type 5 (PDE5) Inhibitor (2014-2024)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis AG
2.3.1 Business Overview
2.3.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.7 SK Chemicals
2.7.1 Business Overview
2.7.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.8 GlaxoSmithKline plc
2.8.1 Business Overview
2.8.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.9 Merck
2.9.1 Business Overview
2.9.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.10 BaiYunShan General Factory
2.10.1 Business Overview
2.10.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.11 Vectura Group
2.11.1 Business Overview
2.11.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.12 Teva Pharma
2.12.1 Business Overview
2.12.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.13 Seoul Pharma
2.13.1 Business Overview
2.13.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.14 Dong-A ST
2.14.1 Business Overview
2.14.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.15 Metuchen Pharma
2.15.1 Business Overview
2.15.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
3 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Competition, by Players
3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Phosphodiesterase Type 5 (PDE5) Inhibitor Players Market Share
3.2.2 Top 10 Phosphodiesterase Type 5 (PDE5) Inhibitor Players Market Share
3.3 Market Competition Trend
4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Regions
4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Market Share by Regions
4.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
4.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
4.5 South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
5 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries
5.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries (2014-2019)
5.2 USA Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
5.3 Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
5.4 Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
6 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries
6.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries (2014-2019)
6.2 Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
6.3 UK Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
6.4 France Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
6.5 Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
6.6 Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries
7.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries (2014-2019)
7.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
7.3 Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
7.4 Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
7.5 India Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
8 South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries
8.1 South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries (2014-2019)
8.2 Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
8.3 Argentina Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
8.4 Colombia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Phosphodiesterase Type 5 (PDE5) Inhibitor by Countries
9.1 Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries (2014-2019)
9.2 Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
9.3 UAE Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
9.4 Egypt Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
9.5 Nigeria Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
9.6 South Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
10 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Segment by Type
10.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Market Share by Type (2014-2019)
10.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast by Type (2019-2024)
10.3 Sildenafil Revenue Growth Rate (2014-2024)
10.4 Tadalafil Revenue Growth Rate (2014-2024)
10.5 Avanafil Revenue Growth Rate (2014-2024)
10.6 Vardenafil Revenue Growth Rate (2014-2024)
11 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Segment by Application
11.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Application (2014-2019)
11.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Retail Pharmacy Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast (2019-2024)
12.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast (2019-2024)
12.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast by Regions (2019-2024)
12.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
12.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
12.6 South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Picture
Table Product Specifications of Phosphodiesterase Type 5 (PDE5) Inhibitor
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor and Revenue (Million USD) Market Split by Product Type
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Types in 2018
Figure Sildenafil Picture
Figure Tadalafil Picture
Figure Avanafil Picture
Figure Vardenafil Picture
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) by Application (2014-2024)
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacies Picture
Figure Other Picture
Table Global Market Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table SK Chemicals Basic Information, Manufacturing Base and Competitors
Table SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table BaiYunShan General Factory Basic Information, Manufacturing Base and Competitors
Table BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Vectura Group Basic Information, Manufacturing Base and Competitors
Table Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharma Basic Information, Manufacturing Base and Competitors
Table Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Seoul Pharma Basic Information, Manufacturing Base and Competitors
Table Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Dong-A ST Basic Information, Manufacturing Base and Competitors
Table Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Metuchen Pharma Basic Information, Manufacturing Base and Competitors
Table Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Type and Applications
Table Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) by Players (2014-2019)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Players (2014-2019)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Players in 2017
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Players in 2018
Figure Global Top 5 Players Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share in 2018
Figure Global Top 10 Players Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share in 2018
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) by Regions (2014-2019)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Regions (2014-2019)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Regions (2014-2019)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Regions in 2018
Figure North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Table North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries (2014-2019)
Table North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries (2014-2019)
Figure North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries (2014-2019)
Figure North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries in 2018
Figure USA Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Table Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) by Countries (2014-2019)
Figure Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries in 2018
Figure Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure UK Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure France Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries in 2018
Figure China Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure India Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Table South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Countries (2014-2019)
Table South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries (2014-2019)
Figure South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries (2014-2019)
Figure South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries in 2018
Figure Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Argentina Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Colombia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Countries in 2018
Figure Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure UAE Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Egypt Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure Nigeria Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Figure South Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Growth Rate (2014-2019)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) by Type (2014-2019)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Type (2014-2019)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Type (2014-2019)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Type in 2018
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Forecast by Type (2019-2024)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share Forecast by Type (2019-2024)
Figure Global Sildenafil Revenue Growth Rate (2014-2019)
Figure Global Tadalafil Revenue Growth Rate (2014-2019)
Figure Global Avanafil Revenue Growth Rate (2014-2019)
Figure Global Vardenafil Revenue Growth Rate (2014-2019)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Application (2014-2019)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application (2014-2019)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application (2014-2019)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application in 2018
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Forecast by Application (2019-2024)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
Figure Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
Figure South America Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Forecast (2019-2024)
カテプシンK阻害剤市場：世界及び中国市場分析・予測（～2024年） Cathepsin K Inhibitor Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cathepsin K Inhibitor industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cathepsin K Inhibitor manu…- クロムミスト抑制剤市場：世界及び中国市場分析・予測（～2024年） Chromium Mist Inhibitor Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Chromium Mist Inhibitor industry with a focus on the Chinese market. The report provides key statistics on the market status of the Chromium Mist Inhibito…
- 有機リン腐食抑制剤市場：世界及び中国市場分析・予測（～2024年） Organophosphor Corrosion Inhibitor Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Organophosphor Corrosion Inhibitor industry with a focus on the Chinese market. The report provides key statistics on the market status of the …
- 乾燥人血液凝固因子抗体迂回活性複合体市場：世界及び中国市場分析・予測（～2024年） Anti-Inhibitor Coagulant Complex Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Anti-Inhibitor Coagulant Complex industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anti…
- プロトンポンプ阻害薬市場：世界及び中国市場分析・予測（～2024年） Proton Pump Inhibitor Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Proton Pump Inhibitor Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Proton Pump Inhi…